Yes, glycopeptides can serve as therapeutic targets. Certain antibiotics, such as vancomycin, are glycopeptide-based and are used to treat bacterial infections. These antibiotics work by inhibiting cell wall synthesis in bacteria. Moreover, targeting abnormal glycosylation pathways is a promising strategy for developing new therapies for various diseases.
